Redsense Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	31.84	28.77	25.52	16.75	16.34	17.1
Other Revenue	-0	-	-	0	-	-
Revenue	31.84	28.77	25.52	16.75	16.34	17.1
Revenue Growth (YoY)	31.49%	12.74%	52.32%	2.51%	-4.43%	20.19%
Cost of Revenue	12.99	10.69	12.36	5.49	5.95	7.14
Gross Profit	18.85	18.08	13.16	11.27	10.4	9.96
Selling, General & Admin	16.92	19.76	17.54	22.46	22.77	16.6
Other Operating Expenses	0.18	-1.96	0.59	-1.04	-0.56	1.25
Operating Expenses	17.39	17.87	18.2	21.47	22.39	18.08
Operating Income	1.46	0.21	-5.04	-10.21	-11.99	-8.12
Interest Expense	-0.04	-0.04	-0.03	-0.1	-0.05	-0.04
Interest & Investment Income	0.23	0.17	0.06	1.02	1.05	0.16
Earnings From Equity Investments	-	-	-	-	-0.3	-
Currency Exchange Gain (Loss)	-1.35	-	-	2.5	-	-
Other Non Operating Income (Expenses)	-0	-	-	-0	0	-
EBT Excluding Unusual Items	0.3	0.34	-5.01	-6.79	-11.29	-8.01
Gain (Loss) on Sale of Investments	-	-	0.5	-1.97	3.32	-1.03
Pretax Income	0.3	0.34	-4.51	-8.76	-7.97	-9.03
Net Income	0.3	0.34	-4.51	-8.76	-7.97	-9.03
Net Income to Common	0.3	0.34	-4.51	-8.76	-7.97	-9.03
Shares Outstanding (Basic)	17	17	14	14	14	14
Shares Outstanding (Diluted)	17	17	14	14	14	14
Shares Change (YoY)	267.27%	21.25%	-0.16%	0.60%	-	15.33%
EPS (Basic)	0.02	0.02	-0.32	-0.62	-0.57	-0.64
EPS (Diluted)	0.02	0.02	-0.32	-0.62	-0.57	-0.64
Free Cash Flow	-2.89	-8.25	-5.1	-9.83	-12.58	-6.64
Free Cash Flow Per Share	-0.17	-0.48	-0.36	-0.70	-0.90	-0.47
Dividend Per Share	-	-	-	-	-	2.140
Gross Margin	59.20%	62.83%	51.56%	67.24%	63.63%	58.22%
Operating Margin	4.59%	0.73%	-19.74%	-60.93%	-73.37%	-47.50%
Profit Margin	0.95%	1.19%	-17.69%	-52.27%	-48.78%	-52.83%
Free Cash Flow Margin	-9.09%	-28.66%	-20.00%	-58.68%	-76.98%	-38.85%
EBITDA	1.75	0.28	-4.98	-10.16	-11.97	-8.09
EBITDA Margin	5.50%	0.96%	-19.50%	-60.61%	-73.21%	-47.33%
D&A For EBITDA	0.29	0.07	0.06	0.05	0.03	0.03
EBIT	1.46	0.21	-5.04	-10.21	-11.99	-8.12
EBIT Margin	4.59%	0.73%	-19.74%	-60.93%	-73.37%	-47.50%
Revenue as Reported	33.56	32.63	25.56	17.79	16.9	17.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.